Nivolumab therapy for treatment-related vitiligo in a patient with relapsed metastatic melanoma

JAMA Dermatology

Volumn 153, Issue 9, 2017, Pages 942-944

  Nakamura, Yasuhiro ^a   Teramoto, Yukiko ^a   Asami, Yuri ^a   Matsuya, Taisuke ^a   Adachi, Jun Ichi ^a   Nishikawa, Ryo ^a   Yamamoto, Akifumi ^a  

^a SAITAMA MEDICAL UNIVERSITY INTERNATIONAL MEDICAL CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

NIVOLUMAB; IMMUNOLOGICAL ANTINEOPLASTIC AGENT;

ADULT; ARTICLE; BIOPSY; BRAIN METASTASIS; CASE REPORT; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; HISTOLOGY; HUMAN; ILIOINGUINAL LYMPHADENECTOMY; IMMUNOHISTOCHEMISTRY; LIVER METASTASIS; LYMPH NODE DISSECTION; MALE; METASTASIS; METASTATIC MELANOMA; MICROMETASTASIS; MULTIPLE CYCLE TREATMENT; PELVIC METASTASIS; PRIORITY JOURNAL; RECURRENT DISEASE; RELAPSE; SENTINEL NODE BIOPSY; SENTINEL NODE MICROMETASTASIS; STEREOTACTIC BODY RADIATION THERAPY; VITILIGO; WIDE EXCISION; COMPLICATION; MELANOMA; PATHOLOGY; SECONDARY; SKIN; TUMOR RECURRENCE;

ADULT; ANTINEOPLASTIC AGENTS, IMMUNOLOGICAL; BIOPSY; HUMANS; MALE; MELANOMA; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; NIVOLUMAB; SKIN; VITILIGO;

EID: 85029503073     PISSN: 21686068     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamadermatol.2017.1679     Document Type: Article

References (6)

1. Schallreuter KU, Levenig C, Berger J. Vitiligo and cutaneous melanoma: a case study. Dermatologica. 1991;183(4):239-245.
2. Nakamura Y, Tanaka R, Asami Y, et al. Correlation between vitiligo occurrence and clinical benefit in advanced melanoma patients treated with nivolumab: a multi-institutional retrospective study [published online August 11, 2016]. J Dermatol. 2016. doi:10.1111/1346-8138.13520
3. Hua C, Boussemart L, Mateus C, et al. Association of vitiligo with tumor response in patients with metastatic melanoma treated with pembrolizumab. JAMA Dermatol. 2016;152(1):45-51.
4. Freeman-Keller M, Kim Y, Cronin H, Richards A, Gibney G, Weber JS. Nivolumab in resected and unresectable metastatic melanoma: characteristics of immune-related adverse events and association with outcomes. Clin Cancer Res. 2016;22(4):886-894.
5. Stierman SC, Tierney EP, Shwayder TA. Halo congenital nevocellular nevi associated with extralesional vitiligo: a case series with review of the literature. Pediatr Dermatol. 2009;26(4):414-424.
6. Workman M, Sawan K, El Amm C. Resolution and recurrence of vitiligo following excision of congenital melanocytic nevus. Pediatr Dermatol. 2013;30 (6):e166-e168.